Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Schijf, Marcel A ^a,b   Lukens, Michael V ^a   Kruijsen, Debby ^a   Van Uden, Nathalie O P ^a   Garssen, Johan ^b,d   Coenjaerts, Frank E J ^c   Van't Land, Belinda ^a,b   Van Bleek, Grada M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; PATTERN RECOGNITION RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY;

ARTICLE; BONE MARROW CELL; CELL INTERACTION; CELL ISOLATION; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EPITHELIUM CELL; EXPOSURE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOLECULAR INTERACTION; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS ATTACHMENT;

ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, CD14; CELL COMMUNICATION; CELL CULTURE TECHNIQUES; CELL LINE; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERFERON TYPE I; LEUKOCYTES, MONONUCLEAR; MONOCYTES; RECEPTORS, INTERFERON; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 7; VIRUS ATTACHMENT;

EID: 84896727142     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081695     Document Type: Article

References (73)

1. Janeway CA (1989) Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symposia on Quantitative Biology 54 1: 1-13.
2. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384. doi:10.1038/ni.1863. PubMed: 20404851.
3. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM et al. (2009) The burden of respiratory syncytial virus infection in young children. N Engl J Med 360: 588-598. doi:10.1056/NEJMoa0804877. PubMed: 19196675.
4. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE (2005) Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352: 1749-1759. doi:10.1056/NEJMoa043951. PubMed: 15858184. (Pubitemid 40570923)
5. Van Drunen Littel-van den Hurk S, Watkiss ER (2012) Pathogenesis of respiratory syncytial virus. Curr Opin Virol 2: 300-305. doi:10.1016/j.coviro. 2012.01.008. PubMed: 22709517.
6. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128. doi:10.1016/S0140-6736(12)61728-0. PubMed: 23245604.
7. Blasius AL, Beutler B (2010) Intracellular toll-like receptors. Immunity 32: 305-315. doi:10.1016/j.immuni.2010.03.012. PubMed: 20346772.
8. Pichlmair A, Schulz O, Tan CP, Näslund TI, Liljeström P et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science (New York, NY) 314: 997-1001. doi:10.1126/science. 1132998. (Pubitemid 44749946)
9. Hornung V, Ellegast J, Kim S, Brzózka K, Jung A et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science (New York, NY) 314: 994-997. doi:10.1126/science.1132505.
10. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105. doi:10.1038/nature04734. PubMed: 16625202.
11. Barral PM, Sarkar D, Su ZZ, Barber GN, DeSalle R et al. (2009) Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity. Pharmacol Ther 124: 219-234. PubMed: 19615405.
12. Le Bon A, Tough DF (2002) Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14: 432-436. doi:10.1016/S0952-7915(02) 00354-0. PubMed: 12088676. (Pubitemid 34671244)
13. Murawski MR, Bowen GN, Cerny AM, Anderson LJ, Haynes LM et al. (2009) Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol 83: 1492-1500. doi:10.1128/JVI.00671-08. PubMed: 19019963.
14. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP et al. (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1: 398-401. doi:10.1038/80833. PubMed: 11062499.
15. Delgado MF, Coviello S, Monsalvo AC, Melendi GA, Hernandez JZ et al. (2009) Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 15: 34-41. doi:10.1038/nm.1894. PubMed: 19079256.
16. Boukhvalova MS, Prince GA, Soroush L, Harrigan DC, Vogel SN et al. (2006) The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease. Vaccine 24: 5027-5035. doi:10.1016/j.vaccine.2006.03.064. PubMed: 16675071. (Pubitemid 43782692)
17. Rudd BD, Smit JJ, Flavell RA, Alexopoulou L, Schaller MA et al. (2006) Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. Journal of Immunology (Baltimore, Md□?: 1950) 176: 1937-1942. PubMed: 16424225.
18. Lukacs NW, Smit JJ, Mukherjee S, Morris SB, Nunez G et al. (2010) Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. Journal of Immunology (Baltimore, Md□?: 1950) 185: 2231-2239. PubMed: 20624950.
19. Haeberle HA, Takizawa R, Casola A, Brasier AR, Dieterich H-J et al. (2002) Respiratory syncytial virus-induced activation of nuclear factorkappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J Infect Dis 186: 1199-1206. doi:10.1086/344644. PubMed: 12402188. (Pubitemid 35192997)
20. Klein Klouwenberg P, Tan L, Werkman W, Van Bleek GM, Coenjaerts F (2009) The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus. Crit Rev Immunol 29: 531-550. doi:10.1615/ CritRevImmunol.v29.i6.40. PubMed: 20121698.
21. Lukacs NW, Smit JJ, Schaller MA, Lindell DM (2008) Regulation of immunity to respiratory syncytial virus by dendritic cells, toll-like receptors, and notch. Viral Immunol 21: 115-122. doi:10.1089/vim.2007.0110. PubMed: 18419253. (Pubitemid 351873371)
22. Groskreutz DJ, Monick MM, Powers LS, Yarovinsky TO, Look DC et al. (2006) Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. Journal of Immunology (Baltimore, Md□?: 1950) 176: 1733-1740. PubMed: 16424203.
23. Van Diepen A, Brand HK, Sama I, Lambooy LHJ, Van den Heuvel LP et al. (2010) Quantitative proteome profiling of respiratory virus-infected lung epithelial cells. J Proteomics 73: 1680-1693. doi:10.1016/j.jprot.2010.04.008. PubMed: 20470912.
24. Swedan S, Andrews J, Majumdar T, Musiyenko A, Barik S (2011) Multiple functional domains and complexes of the two nonstructural proteins of human respiratory syncytial virus contribute to interferon suppression and cellular location. J Virol 85: 10090-10100. doi:10.1128/JVI.00413-11. PubMed: 21795342.
25. Villenave R, Thavagnanam S, Sarlang S, Parker J, Douglas I et al. (2012) In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc Natl Acad Sci U S A 109: 5040-5045. doi:10.1073/pnas.1110203109. PubMed: 22411804.
26. Schlender J, Hornung V, Finke S, Günthner-Biller M, Marozin S et al. (2005) Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 79: 5507-5515. doi:10.1128/JVI.79.9.5507-5515.2005. PubMed: 15827165. (Pubitemid 40548219)
27. Hornung V, Schlender J, Guenthner-Biller M, Rothenfusser S, Endres S et al. (2004) Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. Journal of Immunology (Baltimore, Md□?: 1950) 173: 5935-5943. PubMed: 15528327.
28. Johnson TR, Johnson CN, Corbett KS, Edwards GC, Graham BS (2011) Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus. PLOS ONE 6: e16458. doi:10.1371/journal.pone.0016458. PubMed: 21297989.
29. Johnson TR, McLellan JS, Graham BS (2012) Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2. J Virol 86: 1339-1347. doi:10.1128/JVI.06096-11. PubMed: 22090124.
30. Jie Z, Dinwiddie DL, Senft AP, Harrod KS (2011) Regulation of STAT signaling in mouse bone marrow derived dendritic cells by respiratory syncytial virus. Virus Res 156: 127-133. doi:10.1016/j.virusres.2011.01.007. PubMed: 21255624.
31. Rudd BD, Schaller MA, Smit JJ, Kunkel SL, Neupane R et al. (2007) MyD88-mediated instructive signals in dendritic cells regulate pulmonary immune responses during respiratory virus infection. Journal of Immunology (Baltimore, Md□?: 1950) 178: 5820-5827. PubMed: 17442966.
32. Wang H, Peters N, Schwarze J (2006) Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. Journal of Immunology (Baltimore, Md□?: 1950) 177: 6263-6270. PubMed: 17056556.
33. Ubol S, Halstead SB (2010) How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vaccine Immunol 17: 1829-1835. doi:10.1128/CVI.00316-10. PubMed: 20876821.
34. Jiang Z, Kunimoto M, Patel JA (1998) Autocrine regulation and experimental modulation of interleukin-6 expression by human pulmonary epithelial cells infected with respiratory syncytial virus. J Virol 72: 2496-2499. PubMed: 9499112. (Pubitemid 28100812)
35. Spann KM, Tran K-C, Chi B, Rabin RL, Collins PL (2004) Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 78: 4363-4369. doi:10.1128/JVI.78.8.4363-4369.2004. PubMed: 15047850. (Pubitemid 38437240)
36. Mastronarde JG, Monick MM, Mukaida N, Matsushima K, Hunninghake GW (1998) Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-kappaB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis 177: 1275-1281. doi:10.1086/515279. PubMed: 9593012. (Pubitemid 28194266)
37. Hallak LK, Spillmann D, Collins PL, Peeples ME (2000) Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 74: 10508-10513. doi:10.1128/JVI.74.22.10508-10513.2000. PubMed: 11044095.
38. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A (2003) Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 198: 513-520. doi:10.1084/jem.20030162. PubMed: 12900525. (Pubitemid 36976063)
39. Poth JM, Coch C, Busch N, Boehm O, Schlee M et al. (2010) Monocyte-mediated inhibition of TLR9-dependent IFN-α induction in plasmacytoid dendritic cells questions bacterial DNA as the active ingredient of bacterial lysates. Journal of Immunology (Baltimore, Md?□: 1950) 185: 7367-7373. PubMed: 21057083.
40. Rallabhandi P, Phillips RL, Boukhvalova MS, Pletneva LM, Shirey KA et al. (2012) Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2. mBio 3. PubMed: 22872782.
41. Prakash A (2005) Tissue-specific Positive Feedback Requirements for Production of Type I Interferon following Virus. Infection - Journal of Biological Chemistry 280: 18651-18657. doi:10.1074/jbc.M501289200.
42. Ng CS, Kato H, Fujita T (2012) Recognition of viruses in the cytoplasm by RLRs and other helicases - how conformational changes, mitochondrial dynamics and ubiquitination control innate immune responses. Int Immunol 24: 739-749. doi:10.1093/intimm/dxs099. PubMed: 23087188.
43. Stevens CW, Aravind S, Das S, Davis RL (2013) Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4. Br J Pharmacol 168: 1421-1429. doi:10.1111/bph.12028. PubMed: 23083095.
44. Lukens MV, Kruijsen D, Coenjaerts FEJ, Kimpen JLL, Van Bleek GM (2009) Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J Virol 83: 7235-7243. doi:10.1128/JVI.00452-09. PubMed: 19420085.
45. Demoor T, Petersen BC, Morris S, Mukherjee S, Ptaschinski C et al. (2012) IPS-1 signaling has a nonredundant role in mediating antiviral responses and the clearance of respiratory syncytial virus. Journal of Immunology (Baltimore, Md□?: 1950) 189: 5942-5953.
46. Bhoj VG, Sun Q, Bhoj EJ, Somers C, Chen X et al. (2008) MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus. Proc Natl Acad Sci U S A 105: 14046-14051. doi:10.1073/pnas.0804717105. PubMed: 18780793.
47. Jamaluddin M, Wang S, Garofalo RP, Elliott T, Casola A et al. (2001) IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 280: L248-L257. PubMed: 11159003.
48. Okabayashi T, Kojima T, Masaki T, Yokota S-I, Imaizumi T et al. (2011) Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res 160: 360-366. doi:10.1016/j.virusres.2011.07.011. PubMed: 21816185.
49. Marr N, Turvey SE (2012) Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication. Innate Immun 18: 856-865. Available: http://www.ncbi.nlm.nih.gov/pubmed/22535679. Accessed 18 March 2013 doi:10.1177/1753425912444479. PubMed: 22535679.
50. Lizundia R, Sauter K-S, Taylor G, Werling D (2008) Host species-specific usage of the TLR4-LPS receptor complex. Innate Immun 14: 223-231. doi:10.1177/1753425908095957. PubMed: 18669608.
51. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ et al. (2001) Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 75: 10730-10737. doi:10.1128/JVI.75.22.10730-10737.2001. PubMed: 11602714. (Pubitemid 33031542)
52. Ehl S, Bischoff R, Ostler T, Vallbracht S, Schulte-Mönting J et al. (2004) The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur J Immunol 34: 1146-1153. doi:10.1002/eji. 200324449. PubMed: 15048726. (Pubitemid 39255994)
53. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI (2002) Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 3: 354-359. Available: http://www.ncbi.nlm.nih.gov/pubmed/11912497. Accessed 5 March 2013 doi:10.1038/ni777. PubMed: 11912497.
54. Marr N, Hajjar AM, Shah NR, Novikov A, Yam CS et al. (2010) Substitution of the Bordetella pertussis lipid A phosphate groups with glucosamine is required for robust NF-kappaB activation and release of proinflammatory cytokines in cells expressing human but not murine Toll-like receptor 4-MD-2-CD14. Infect Immun 78: 2060-2069. doi:10.1128/IAI.01346-09. PubMed: 20176798.
55. Benjamin JT, Smith RJ, Halloran BA, Day TJ, Kelly DR et al. (2007) FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activation. Am J Physiol Lung Cell Mol Physiol 292: L550-L558. PubMed: 17071719.
56. Benjamin JT, Carver BJ, Plosa EJ, Yamamoto Y, Miller JD et al. (2010) NF-kappaB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression. Journal of Immunology (Baltimore, Md□?: 1950) 185: 4896-4903. PubMed: 20861353.
57. Schijf MA, Kruijsen D, Bastiaans J, Coenjaerts FEJ, Garssen J et al. (2012) Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model. J Virol 86: 11472-11482. doi:10.1128/JVI.06708-11. PubMed: 22896622.
58. Jiang Z, Georgel P, Du X, Shamel L, Sovath S et al. (2005) CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6: 565-570. doi:10.1038/ni1207. PubMed: 15895089. (Pubitemid 41710726)
59. Baumann CL, Aspalter IM, Sharif O, Pichlmair A, Blüml S et al. (2010) CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med 207: 2689-2701. doi:10.1084/jem.20101111. PubMed: 21078886.
60. Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC et al. (2002) Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 297: 2063-2066. doi:10.1126/science. 1074900. PubMed: 12242445.
61. Kadowaki N, Antonenko S, Lau JY, Liu YJ (2000) Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192: 219-226. doi:10.1084/jem.192.2.219. PubMed: 10899908.
62. Kim D, Niewiesk S (2013) Synergistic Induction of Interferon α through TLR-3 and TLR-9 Agonists Identifies CD21 as Interferon α Receptor for the B Cell. Response - PLOS Pathogens 9: e1003233.
63. Szabo G, Dolganiuc A (2008) The role of plasmacytoid dendritic cell-derived IFN alpha in antiviral immunity. Crit Rev Immunol 28: 61-94. doi:10.1615/CritRevImmunol.v28.i1.40. PubMed: 18298384. (Pubitemid 351264075)
64. Smit JJ, Rudd BD, Lukacs NW (2006) Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 203: 1153-1159. doi:10.1084/jem.20052359. PubMed: 16682497. (Pubitemid 43736586)
65. Ling Z, Tran KC, Teng MN (2009) Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J Virol 83: 3734-3742. doi:10.1128/JVI.02434-08. PubMed: 19193793.
66. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531. doi:10.1126/science.1093616. PubMed: 14976261. (Pubitemid 38314425)
67. Sun X, Yau VK, Briggs BJ, Whittaker GR (2005) Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology 338: 53-60. doi:10.1016/j.virol.2005.05.006. PubMed: 15936793. (Pubitemid 40835926)
68. Srinivasakumar N, Ogra PL, Flanagan TD (1991) Characteristics of fusion of respiratory syncytial virus with HEp-2 cells as measured by R18 fluorescence dequenching assay. J Virol 65: 4063-4069. PubMed: 1906550.
69. Morris S, Swanson MS, Lieberman A, Reed M, Yue Z et al. (2011) Autophagy-mediated dendritic cell activation is essential for innate cytokine production and APC function with respiratory syncytial virus responses. Journal of Immunology (Baltimore, Md?□: 1950) 187: 3953-3961. PubMed: 21911604.
70. Liao AP, Salajegheh M, Morehouse C, Nazareno R, Jubin RG et al. (2010) Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon production. Clin Immunol 136: 130-138. doi:10.1016/j.clim.2010.02.014. PubMed: 20346735.
71. Spann KM, Tran KC, Collins PL (2005) Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J Virol 79: 5353-5362. doi:10.1128/JVI.79.9.5353-5362.2005. PubMed: 15827150. (Pubitemid 40548204)
72. Lo MS, Brazas RM, Holtzman MJ (2005) Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79: 9315-9319. doi:10.1128/JVI.79.14.9315-9319.2005. PubMed: 15994826. (Pubitemid 40934843)
73. De Jager W, Prakken B, Rijkers GT (2009) Cytokine multiplex immunoassay: methodology and (clinical) applications. Methods Mol Biol 514: 119-133. doi:10.1007/978-1-60327-527-9-9. PubMed: 19048217.